Takehiro Yamaguchi

1.2k total citations
43 papers, 926 citations indexed

About

Takehiro Yamaguchi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Takehiro Yamaguchi has authored 43 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Infectious Diseases. Recurrent topics in Takehiro Yamaguchi's work include Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (5 papers) and Extracellular vesicles in disease (5 papers). Takehiro Yamaguchi is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (5 papers) and Extracellular vesicles in disease (5 papers). Takehiro Yamaguchi collaborates with scholars based in Japan, Indonesia and Russia. Takehiro Yamaguchi's co-authors include Mayuko Osada‐Oka, Yasukatsu Izumi, Masayuki Shiota, Hiroshi Iwao, Masako Tanaka, Minoru Yoshiyama, Ivan F. McMurtry, David M. Rodman, Richard F. OʼBrien and Soichi Sano and has published in prestigious journals such as Nucleic Acids Research, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Takehiro Yamaguchi

39 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takehiro Yamaguchi Japan 16 484 253 169 168 117 43 926
Mark Warnock United States 16 323 0.7× 194 0.8× 146 0.9× 133 0.8× 182 1.6× 33 1.4k
Hadj Ahmed Mostefai France 11 606 1.3× 160 0.6× 185 1.1× 108 0.6× 100 0.9× 13 953
Bao Sun China 19 738 1.5× 393 1.6× 69 0.4× 162 1.0× 90 0.8× 34 1.3k
Mahvash Sadeghi Iran 18 368 0.8× 154 0.6× 71 0.4× 128 0.8× 93 0.8× 39 991
Yanjia Chen China 15 376 0.8× 93 0.4× 144 0.9× 82 0.5× 93 0.8× 37 811
Venkatesh Lakshminarayanan United States 9 418 0.9× 210 0.8× 167 1.0× 114 0.7× 86 0.7× 11 1.1k
Fangfang Zhang China 19 726 1.5× 256 1.0× 60 0.4× 62 0.4× 100 0.9× 50 1.1k
Changsen Wang Canada 17 384 0.8× 80 0.3× 94 0.6× 153 0.9× 158 1.4× 26 1.0k

Countries citing papers authored by Takehiro Yamaguchi

Since Specialization
Citations

This map shows the geographic impact of Takehiro Yamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiro Yamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiro Yamaguchi more than expected).

Fields of papers citing papers by Takehiro Yamaguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takehiro Yamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiro Yamaguchi. The network helps show where Takehiro Yamaguchi may publish in the future.

Co-authorship network of co-authors of Takehiro Yamaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Takehiro Yamaguchi. A scholar is included among the top collaborators of Takehiro Yamaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehiro Yamaguchi. Takehiro Yamaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakao, Ryoma, Takehiro Yamaguchi, Kimihiro Abe, et al.. (2025). Assessment of periodontitis vaccine using three different bacterial outer membrane vesicles in canine model. mSphere. 10(4). e0103324–e0103324.
2.
Nakao, Ryoma, Satoru Hirayama, Takehiro Yamaguchi, et al.. (2023). A bivalent outer membrane vesicle-based intranasal vaccine to prevent infection of periodontopathic bacteria. Vaccine. 41(30). 4369–4383. 11 indexed citations
3.
Nishiyama, Akihito, Yuriko Ozeki, Yoshitaka Tateishi, et al.. (2023). Mycobacterial DNA-binding protein 1 is critical for BCG survival in stressful environments and simultaneously regulates gene expression. Scientific Reports. 13(1). 14157–14157. 5 indexed citations
4.
Nishiyama, Akihito, Takehiro Yamaguchi, Hiroshi Hamamoto, et al.. (2022). Lysocin E Targeting Menaquinone in the Membrane of Mycobacterium tuberculosis Is a Promising Lead Compound for Antituberculosis Drugs. Antimicrobial Agents and Chemotherapy. 66(9). e0017122–e0017122. 6 indexed citations
5.
Nishiuchi, Yukiko, Yoshitaka Tateishi, Hiroshi Hirano, et al.. (2022). Direct Attachment with Erythrocytes Augments Extracellular Growth of Pathogenic Mycobacteria. Microbiology Spectrum. 10(2). e0245421–e0245421.
6.
Yokoe, Shunichi, Tetsuya Hayashi, Takatoshi Nakagawa, et al.. (2022). Augmented O-GlcNAcylation exacerbates right ventricular dysfunction and remodeling via enhancement of hypertrophy, mitophagy, and fibrosis in mice exposed to long-term intermittent hypoxia. Hypertension Research. 46(3). 667–678. 13 indexed citations
7.
Uchida, Junji, Shinji Matsunaga, Kentaro Tokudome, et al.. (2020). Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice. Journal of Pharmacological Sciences. 143(2). 122–126. 15 indexed citations
8.
Nakagawa, Takatoshi, Yuichi Furukawa, Tetsuya Hayashi, et al.. (2019). Augmented O-GlcNAcylation attenuates intermittent hypoxia-induced cardiac remodeling through the suppression of NFAT and NF-κB activities in mice. Hypertension Research. 42(12). 1858–1871. 14 indexed citations
9.
Matsunaga, Shinji, Masayuki Shiota, Takehiro Yamaguchi, et al.. (2019). Controlling the Phenotype of Tumor-Infiltrating Macrophages via the PHD-HIF Axis Inhibits Tumor Growth in a Mouse Model. iScience. 19. 940–954. 23 indexed citations
10.
Kabei, Kazuya, Masayuki Shiota, Mayuko Osada‐Oka, et al.. (2019). Effects of orally active hypoxia inducible factor alpha prolyl hydroxylase inhibitor, FG4592 on renal fibrogenic potential in mouse unilateral ureteral obstruction model. Journal of Pharmacological Sciences. 142(3). 93–100. 27 indexed citations
11.
Nishiyama, Akihito, Takehiro Yamaguchi, Yoshitaka Tateishi, et al.. (2018). C-terminal intrinsically disordered region-dependent organization of the mycobacterial genome by a histone-like protein. Scientific Reports. 8(1). 8197–8197. 10 indexed citations
12.
Kato, Ryuji, Yoshio Ijiri, Takehiro Yamaguchi, et al.. (2018). Factor Xa inhibition by rivaroxaban attenuates cardiac remodeling due to intermittent hypoxia. Journal of Pharmacological Sciences. 137(3). 274–282. 23 indexed citations
13.
Yamaguchi, Takehiro, Masako Tanaka, Masayuki Shiota, et al.. (2018). A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4. Journal of Pharmacological Sciences. 139(2). 112–119. 18 indexed citations
14.
Kato, Ryuji, et al.. (2017). RIVAROXABAN ATTENUATES CARDIAC REMODELING DUE TO INTERMITTENT HYPOXIA BY SUPPRESSING THE SYNERGISTIC EFFECTS OF PAR-1 AND PAR-2. Journal of the American College of Cardiology. 69(11). 2033–2033. 2 indexed citations
15.
Matsushima, Miyoko, Takehiro Yamaguchi, Naozumi Hashimoto, et al.. (2017). Modulation of immunological activity on macrophages induced by diazinon. Toxicology. 379. 22–30. 30 indexed citations
16.
Yamaguchi, Takehiro, Takanori Yamazaki, Yasuhiro Nakamura, et al.. (2015). Percutaneous carbon dioxide mist treatment has protective effects in experimental myocardial infarction. Journal of Pharmacological Sciences. 127(4). 474–480. 3 indexed citations
17.
Yamaguchi, Takehiro, Takanori Yamazaki, Hiroaki Kawaguchi, et al.. (2014). A Noninvasive Metabolic Syndrome Model Using an Extremely Small Minipig, the Microminipig. Journal of Pharmacological Sciences. 126(2). 168–171. 5 indexed citations
18.
Sano, Soichi, Yasukatsu Izumi, Takehiro Yamaguchi, et al.. (2014). Lipid synthesis is promoted by hypoxic adipocyte-derived exosomes in 3T3-L1 cells. Biochemical and Biophysical Research Communications. 445(2). 327–333. 127 indexed citations
19.
Yamaguchi, Takehiro, Yasukatsu Izumi, Yasuhiro Nakamura, et al.. (2014). Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction. International Journal of Cardiology. 178. 239–246. 142 indexed citations
20.
Suzuki, Toshio, Yukiko Fujiwara, Y. Matsuda, et al.. (1991). DESIGN AND SYNTHESIS OF COLON-SPECIFIC PRO-ANTEDRUGS, 20-GLUCOPYRANOSYLOXY METHYLPREDNISOLONATES, FOR ORAL TREATMENT OF ULCERATIVE COLITIS AND THEIR METABOLISM. Journal of Pharmacobio-Dynamics. 14(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Warnock Breakdown of academic impact, for papers by Hadj Ahmed Mostefai Breakdown of academic impact, for papers by Bao Sun Breakdown of academic impact, for papers by Mahvash Sadeghi Breakdown of academic impact, for papers by Yanjia Chen Breakdown of academic impact, for papers by Venkatesh Lakshminarayanan Breakdown of academic impact, for papers by Fangfang Zhang Breakdown of academic impact, for papers by Changsen Wang
Rankless by CCL
2026